These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 53275)

  • 1. A comparison of the encephalitogenic activities of human myelin basic protein and the synthetic peptide determinant comprising residues 114-122.
    McDermott JR; Caspary EA
    J Neurochem; 1975 Nov; 25(5):711-3. PubMed ID: 53275
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-encephalitogenic synthetic analogues of the determinant for allergic encephalomyelitis in guinea pigs.
    Hashim GA; Sharpe RD
    Nature; 1975 Jun; 255(5508):484-5. PubMed ID: 49022
    [No Abstract]   [Full Text] [Related]  

  • 3. Delineation of two encephalitogenic myelin basic protein epitopes for DA rats.
    Smeltz RB; Wolf NA; Swanborg RH
    J Neuroimmunol; 1998 Jul; 87(1-2):43-8. PubMed ID: 9670844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental allergic encephalomyelitis in Lewis rats: chemical synthesis of disease-inducing determinant.
    Hashim GA
    Science; 1977 Jun; 196(4295):1219-21. PubMed ID: 67639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
    Vandenbark AA; Hashim G; Offner H
    Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility to proteolipid apoprotein and its encephalitogenic determinants in mice.
    Endoh M; Kunishita T; Nihei J; Nishizawa M; Tabira T
    Int Arch Allergy Appl Immunol; 1990; 92(4):433-8. PubMed ID: 1707404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-encephalitogenic antigen-induced suppression and reversal of allergic encephalomyelitis.
    Hashim GA
    Nature; 1975 Aug; 256(5518):953-5. PubMed ID: 52118
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis in rabbits. A major encephalitogenic determinant within residues 1-44 of myelin basic protein.
    Kira J; Bacon ML; Martenson RE; Deibler GE; Kies MW; Alvord EC
    J Neuroimmunol; 1986 Sep; 12(3):183-93. PubMed ID: 2426303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs.
    Teitelbaum D; Webb C; Arnon R; Sela M
    Cell Immunol; 1977 Mar; 29(2):265-71. PubMed ID: 67899
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperacute autoimmune encephalomyelitis induced by a synthetic autoantigen.
    Westall FC; Thompson M; Lennon VA
    Nature; 1977 Sep; 269(5627):425-7. PubMed ID: 71663
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the inactivation of encephalitogenic myelin basic protein by serum.
    McDermott JR; Keith AB
    Acta Neurol Scand; 1979 Sep; 60(3):140-8. PubMed ID: 92876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein.
    Sakai K; Sinha AA; Mitchell DJ; Zamvil SS; Rothbard JB; McDevitt HO; Steinman L
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8608-12. PubMed ID: 2460872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The location of regions in guinea pig and bovine myelin basic proteins which induce experimental allergic encephalomyelitis in Lewis rats.
    Martenson RE; Levine S; Sowindki R
    J Immunol; 1975 Feb; 114(2 Pt 1):592-6. PubMed ID: 47354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular bases for the difference in the potency of myelin basic protein from different species in Lewis rats.
    Hashim GA
    Adv Exp Med Biol; 1978; 100():289-301. PubMed ID: 80942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
    Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L
    J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vaccination with T cell receptor peptides: epitope switching to a possible disease-protective determinant of myelin basic protein that is cross-reactive with a TCR BV peptide.
    Vandenbark AA; Chou YK; Whitham R; Bourdette DN; Offner H
    Immunol Cell Biol; 1998 Feb; 76(1):83-90. PubMed ID: 9553780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides and autoimmune disease.
    Eylar EH
    Adv Exp Med Biol; 1978; 98():259-81. PubMed ID: 82385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants.
    Wall M; Southwood S; Sidney J; Oseroff C; del Guericio MF; Lamont AG; Colón SM; Arrhenius T; Gaeta FC; Sette A
    Int Immunol; 1992 Jul; 4(7):773-7. PubMed ID: 1379827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fusion protein consisting of IL-16 and the encephalitogenic peptide of myelin basic protein constitutes an antigen-specific tolerogenic vaccine that inhibits experimental autoimmune encephalomyelitis.
    Mannie MD; Abbott DJ
    J Immunol; 2007 Aug; 179(3):1458-65. PubMed ID: 17641011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.